Stock 3750 CYTORI CELL RESEARCH INSTITUTE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Cytori Cell Research Institute, Inc.

Equities

3750

JP3426500009

Delayed Japan Exchange
Other stock markets
 02:56:44 04/06/2024 BST 		5-day change 1st Jan Change
1,031 JPY +0.19% Intraday chart for Cytori Cell Research Institute, Inc. +8.53% -9.48%
03-13 Samty Hotel Management K.K. agreed to acquire Hotel Kanazawa Co., Ltd. from Cytori Cell Research Institute, Inc.. CI
2023 Cytori Cell Research Institute,Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Samty Hotel Management K.K. agreed to acquire Hotel Kanazawa Co., Ltd. from Cytori Cell Research Institute, Inc..
CI
Cytori Cell Research Institute,Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Sakurajyuji Co., Ltd. signed an agreement to acquire approximately 1.60% stake in FRACTALE Corporation (TSE : 3750) from Aqua Strategic Investment Business Limited Partnership, managed by ACA Inc. for approximately ¥200 million.
CI
FRACTALE Corporation canceled the acquisition of Cytori Therapeutics inc from HG Capital, The Conscious Group Ltd, Toshiyasu Horie, Tokyo Weld Co., Ltd. and Capital Medica Co.Ltd.
CI
FRACTALE Corporation announced that it has received ¥12.675 million in funding from Japan International Partners LLC
CI
FRACTALE Corporation announced that it expects to receive ¥12.675 million in funding from Japan International Partners LLC
CI
FRACTALE Corporation acquired 91% stake in Alegrox Hotel Management Co., Ltd from Shinji Ezure and others for ¥21.2 million.
CI
FRACTALE Corporation agreed to acquire the remaining 43.63% stake in Cytori Therapeutics inc from HG Capital, The Conscious Group Ltd, Toshiyasu Horie, Tokyo Weld Co., Ltd. and Capital Medica Co.Ltd. for ¥2.1 billion.
CI
Ex-dividend day for final dividend
FA
Osaka Mokuzai Sougo Ichiba Co., Ltd. cancelled the acquisition of Ikeda Fudosan Co., Ltd. from FRACTALE Corporation.
CI
Seijiro Shirahama and FRACTALE Corporation completed the acquisition of Cytori Therapeutics K.K. and Cell Therapy Assets in Japan.
CI
Seijiro Shirahama entered into an asset and equity purchase agreement to acquire Cytori Therapeutics K.K. and Cell Therapy Assets in Japan for $3 million.
CI
Ex-dividend day for final dividend
FA
An individual cancelled the acquisition of International Luxury Media Co., Ltd. from Seven Seas Holdings Co.,Ltd..
CI
Osaka Mokuzai Sougo Ichiba Co., Ltd. signed a contract to acquire Ikeda Fudosan Co., Ltd. from FRACTALE Corporation for ¥1.7 billion.
CI
Seven Seas Holdings Co.,Ltd. cancelled the acquisition of Nuts Real Estate LLC from Nuts Real Estate Institute.
CI
An individual agreed to acquire International Luxury Media Co., Ltd. from Seven Seas Holdings Co.,Ltd. for ¥10 million.
CI
Seven Seas Holdings Co.,Ltd. cancelled the acquisition of Sengokuhara Development Co., Ltd.
CI
Split: 5 of 1
FA
Tranche Update on Seven Seas Holdings Co.,Ltd.'s Equity Buyback Plan announced on June 22, 2017.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 3750 Stock
  4. News Cytori Cell Research Institute, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW